Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli
December 26th, 2020
3.6K views
Here we present a method to express acetylated histone proteins using genetic code expansion and assemble reconstituted nucleosomes in vitro.
Overview
This article details a robust protocol for the site-specific incorporation of Nε-acetyl-lysine (AcK) into histone H3 using the Methanosarcina mazei pyrrolysine tRNA synthetase (MmAcKRS1) and its cognate tRNA in Escherichia coli. The method enables the production of acetylated histone proteins, which are then assembled into reconstituted mononucleosomes. These modified nucleosomes are valuable tools for biochemical assays, binding studies, and structural analyses, facilitating research into epigenetic mechanisms and protein interactions.
Key Study Components
Area of Science
- Epigenetics
- Protein engineering
- Molecular biology
Background
- Histone acetylation is a key post-translational modification involved in chromatin regulation and gene expression.
- Site-specific incorporation of acetyl-lysine into histones is challenging using traditional biochemical methods.
- The MmAcKRS1/tRNAPyl system allows for the genetic encoding of AcK at defined sites in proteins expressed in E. coli.
- Modified mononucleosomes are essential for studying protein-DNA interactions and epigenetic regulation.
Purpose of Study
- To provide a detailed protocol for the site-specific incorporation of AcK into histone H3.
- To assemble acetylated histone proteins into reconstituted mononucleosomes.
- To enable the production of modified nucleosomes for downstream biochemical and structural studies.
Methods Used
- Co-transformation of E. coli with plasmids encoding tagged histone H3 and pEVOL-AcKRS1/tRNAPyl.
- Induction of protein expression with IPTG, arabinose, and AcK supplementation.
- Isolation and purification of acetylated histone proteins via inclusion body preparation, denaturation, and nickel-NTA affinity chromatography.
- Assembly of histone octamers and reconstitution of mononucleosomes using the 601 DNA sequence and stepwise dialysis.
- Assessment of nucleosome assembly by native PAGE and protein quantification.
Main Results
- Efficient incorporation of AcK into histone H3 at specific sites was achieved.
- Acetylated histone proteins were successfully purified and assembled into mononucleosomes.
- Yield of acetylated tetramers varied depending on the modification site, with lower yields observed for modifications closer to the histone core.
- Reconstituted nucleosomes were validated by native PAGE and could be stored for long-term use.
Conclusions
- This protocol enables the site-specific incorporation of acetyl-lysine into histones for the generation of modified mononucleosomes.
- The method is versatile and can be adapted to incorporate other noncanonical amino acids.
- These modified nucleosomes are valuable for investigating epigenetic mechanisms and protein interactions in a chromatin context.
Frequently Asked Questions
What is the main advantage of using the MmAcKRS1/tRNAPyl system for histone acetylation?
The system allows for precise, site-specific incorporation of acetyl-lysine into histones during protein expression in E. coli, enabling the study of defined post-translational modifications.
Can this protocol be adapted for other histone modifications?
Yes, the pyrrolysyl-tRNA synthetase system can be evolved to incorporate various noncanonical amino acids, allowing for diverse site-specific protein modifications.
What are the key steps in assembling acetylated mononucleosomes?
Key steps include expressing and purifying acetylated histones, assembling histone octamers, combining with 601 DNA, and performing stepwise dialysis to reconstitute nucleosomes.
How is the success of nucleosome assembly assessed?
Assembly is validated using native PAGE to observe nucleosome bands and by quantifying protein and DNA concentrations.
What challenges were observed with acetylated histone tetramer yields?
Lower yields were noted for acetylation sites closer to the histone core, likely due to interference with octamer assembly.
How should the modified nucleosomes be stored?
Short-term storage is at 4°C, while long-term storage requires dialysis into storage buffer and freezing at -80°C.
What applications are enabled by these acetylated mononucleosomes?
They can be used in biochemical and binding assays, structural studies, and experiments investigating epigenetic regulation and protein-DNA interactions.
Executive Industry Relevance
Site-specific lysine acetylation of histones using genetic code expansion in Escherichia coli enables precise interrogation of epigenetic modifications in a controlled chromatin context. This capability supports mechanistic de-risking and predictive confidence in early discovery, particularly for target validation and pathway elucidation. The approach provides a scalable platform for generating modified nucleosomes, directly impacting portfolio decisions in epigenetics-focused R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional validation of histone modification sites in nucleosome context.
- Supports mechanistic de-risking by isolating the impact of specific acetylation events.
- Facilitates hypothesis-driven studies of chromatin-mediated gene regulation.
- Provides a platform for interrogating protein-DNA and protein-protein interactions relevant to epigenetic targets.
Screening & Assay Development
- Generates validated, site-specifically modified nucleosomes for downstream biochemical and binding assays.
- Enables reproducible assembly of nucleosome substrates for high-content screening.
- Supports quantitative readouts in structure-function and interaction assays.
- Standardizes assay inputs for comparative compound evaluation.
Translational & Preclinical Research
- Aligns in vitro chromatin models with disease-relevant epigenetic states.
- Enables continuity from discovery through preclinical validation of epigenetic mechanisms.
- Supports risk-adjusted advancement of epigenetic modulators by providing predictive in vitro systems.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from early mechanistic studies to lead identification and preclinical validation for epigenetic targets.
- Discovery Biology: Provides a robust system for testing the functional consequences of site-specific histone acetylation.
- Screening: Supplies standardized, modified nucleosomes for reproducible assay development and screening workflows.
- Analytics: Enables quantitative measurement of nucleosome assembly and modification status for comparative analyses.
- Translational Research: Bridges in vitro findings to disease-relevant chromatin contexts, supporting biomarker alignment.
- Enterprise Reuse: Offers a modular platform adaptable to other noncanonical amino acid incorporations for diverse protein engineering needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and reduces mechanistic ambiguity in epigenetic research.
- Operational Value: Delivers standardized, reproducible, and scalable production of modified nucleosomes.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling robust mechanistic studies early in the pipeline.
- Portfolio Impact: Supports risk-adjusted prioritization of epigenetic targets and programs.
Implementation Considerations
- Requires expertise in molecular cloning, protein expression, and chromatin biochemistry.
- Needs access to analytical infrastructure for protein purification and nucleosome assembly validation.
- Demands cross-team standardization for reproducibility in assay development and screening.
- Adaptable to various histone sites and noncanonical amino acids with appropriate system evolution.
- Yield limitations may occur for modifications near the histone core, impacting scalability for certain sites.
Biopharma FAQs
Why does null hypothesis testing matter for site-specific histone acetylation?
Null hypothesis testing enables rigorous evaluation of whether specific lysine acetylation events alter nucleosome function or interactions, supporting confident target validation in epigenetic research pipelines.
How does independent variable isolation fit nucleosome reconstitution workflows?
By incorporating acetyl-lysine at defined sites, the protocol isolates the effect of individual modifications, allowing mechanistic studies that clarify causal relationships in chromatin biology.
What do quantitative dependent variable measurements enable in nucleosome assays?
Quantitative measurements of nucleosome assembly and modification status provide reliable data for comparing experimental conditions, supporting reproducibility and robust assay development.
Why are replication requirements critical for cross-functional nucleosome studies?
Replication ensures that observed effects of site-specific acetylation are consistent and reproducible, facilitating collaboration across discovery, screening, and translational teams.
What statistical analysis capabilities are required before implementing acetylated nucleosome assays?
Statistical analysis of assembly efficiency, modification incorporation, and assay outputs is essential to validate system performance and inform go/no-go decisions in R&D workflows.
